Professional Documents
Culture Documents
Supriyanto Kartodarsono
Divisi Endokrinologi dan Metabolik
Departemen Penyakit Dalam
RSUD Dr Moewardi/FK UNS
SURAKARTA
1
“
◆ High prevalence diabetes in elderly is inevitable
◆ Hyperglycaemia in ederly is benign
◆ Reduced life expectancy
◆ Older adult are less capable of self-monitoring their blood
glucose
2
Pathogenesis hyperglycamia in elderly
Coexisting illness
Reduced insulin
Poor nutrtion secretion
Genetic
Increased adipose
tissue
Reduced physical
Medication activity
3
Diabetes in elderly
◆ 50% underdiagnosed à WHY ?
◆ Early sign: metabolic abnormalities
◆ Early symptoms (if any)
v Often gradual onset
v Commonly mistaken for sign of normal
aging
4
Aging and Diabetes
◆ Poor diabetic control exaserbates the
aging process
◆ Poor diabetes control cause age
related disease to develop earlier
◆ Poor diabtes control make co-morbid
condition worse and harder to manage
5
Diabetes assesment in Older Adult
v Physical assesment
v Mobillity/physical activity
v Nutrtional assement
v Cardiovascular assesment
v Neurological assement
v Optlamic assesment
v Renal assement
v Auditory assement
v Immune system
v Psychososial assement
6
Case of mistaken identity
◆ Depression
◆ Polypharmasi
◆ Cognitive Impairment
◆ Urinary incontinence
◆ Injurious falls
◆ Persitent pain
8
9
Accelarated aging
Chronic diabetic complications
DIABETES Comorbidities
MELLITUS
Multiple contributor
Geriatric syndrome
Frailty
Dependency
Poor quality of life
Poor DM care
Treatment Recomendations
◆ Glycaemic control
◆ Hypertension
◆ Lipid
◆ Tobacco cessation
◆ Eye care
◆ Foot care
◆ Nephropathy
◆ Diabetes self management training
10
Treatment Recomendations
11
Glycaemic control
◆ A1c
Ø < 7% in healthy adults with good functional status
Ø < 8% appropriate in:
§ Frail older adult
§ Life expectancy less than 5 years
§ Those whom risk of intesive glycaemic control
outweighs benefits
Ø Frequency
12
Risk of intensive glycaemic control
◆ Hypoglycaemia
◆ Polypharmacy
◆ Drug to drug interaction
◆ Drug to disease interaction
13
Who benefits most from intensive Glycaemic
control
14
Medical Therapy in elderly with Diabetes
◆ Non-insulin drug
Ø Metformin is the drug of choice
Ø DPP4 inhibitors are preferred owing to the lower risk of hypoglycamia
Ø Modern sulfonylurea (glyclacid &glimepiride) may be used in low dose.
Glibenclamid should be avoided
Ø Pioglitazone should bne avoided because of the risk of fracture and heart
failure
Ø SGLT2 inhibitor maybe used in otherwise healthy persons
Ø GLP1 receptor agonis maybe used
15
Medical Therapy in elderly with Diabetes
◆ Insulin therapy
Ø Indication for insulin therapy similar in adults of all age
group
Ø If basal insulin is required, prefer preparation with low risk of
hypoglycaemia
Ø If prandial coverage is necessary, prefer premix insulin
analog with low risk of hypoglycaemia
16
Hyperglycaemia
v Can cause
v Delirium
v Mood swing and irrationality
v Appetide changes
v Sleep disturbances
v Increased risk for:
v Diabetic ketoacidosis
v HHS
17
Hyperglycaemia
◆ Impair cognitive function
◆ Reduce energy
◆ Impairs memory
◆ Decreased wound healing
◆ Increased risk of HHS
◆ Increases urine output à Increased risk opf UTI
◆ Impairs immune system
18
Hypoglycaemia
19
Hypoglycaemia
◆ May cause
Ø Heart arrytmias
Ø Increased risk of falls
Ø Sign and symptomes maybe mask by co-morbidities
io.e. Parkinson’s
Ø Impairs concentration and cognition
Ø Impairs reaction time
20
Diabetes Self-Mangement Training
21
CONCLUSION